Overview
RIMAG GROUP (2522)
Jiangxi Rimag Group Co., Ltd., together with its subsidiaries, invests in and operates medical imaging centers in Mainland China, Hong Kong, Macau, and internat...
- Open
- 4.190
- High
- 4.430
- Low
- 4.155
- Prev. Close
- 4.260
- Volume
- 141.00K
- Turnover
- 611.11K
- Avg Price
- 4.334
- Bid/Ask Ratio
- 73.91%
- Amplitude
- 6.46%
- 52wk High
- 18.510
- Volume Ratio
- 0.23
- Turnover Ratio
- 0.04%
- 52wk Low
- 3.740
- HK Mkt Cap
- 1.48B
- Market CapHKD
- 1.94B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -0.0679
- EPSDynamic
- -0.0710
- EPSStatic
- --
- BVPS
- 5.02
- P/B
- 0.86
- HK Shares
- 343.56M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 450.50M
- Min lot size
- 500
- Currency
- HKD
RIMAG GROUP Analyst Rating
View moreForecast & Rating
May 1, 2026- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
Daily Events
- Nov, 9
Rimag Group closed up 2.2% at HK$4.19, shaping a morning spike-and-fade followed by an afternoon recovery: it jumped about 8% to HK$4.435 by 10:01 BJ time, fell back to HK$4.12 at the morning close, then rebounded from HK$4.12 in the afternoon. Volume was only 17,500 shares and HK$73,113 turnover, with a 0.01% turnover rate amplifying the swing, while recent coverage centred on 7%-8% share-price moves rather than any substantive company announcement. Revenue and earnings diverged: Q2 2026 revenue was HK$296.3 million, up 15.79% year on year, but net profit was a HK$8.02 million loss, down 189.05%, with EPS of -HK$0.0208, a PB of 0.83x and a PE of -61.67x. The price remains below its MA20 of HK$4.543 and MA60 of HK$4.87, down 49.46% year to date, 77.36% below its 52-week high of HK$18.51 and 12.03% above its 52-week low of HK$3.74. Still, the afternoon rebound left the stock at HK$4.19, slightly easing near-term selling pressure.
- Nov, 6
After rallying 7% in the previous session, Rimag Group opened at HK$4.20, briefly touched HK$4.34, then faded through the afternoon to close at the day's low of HK$4.10, down 5.6% from HK$4.345, on only 156,500 shares and HK$654,188 of turnover, a 0.05% turnover rate that amplified the pullback. Revenue growth and profitability diverge: Q2 2026 revenue rose 15.79% year on year to HK$296.3 million, yet net profit swung to a HK$8.02 million loss, down 189%, leaving EPS at -HK$0.0208 and ROE at -1.41%. The price sits below both the MA20 of HK$4.58 and MA60 of HK$4.878, is down 50.54% year to date and 77.85% below the 52-week high of HK$18.51, though still 9.63% above the HK$3.74 low, with PB at 0.82x. While trading has stayed thin since the interim report, daily swings remain sensitive to small flows.
- Nov, 5
Rimag Group rebounded from an early dip to close at HK$4.345, up 5.7% from the prior HK$4.110, on turnover of just HK$331,258 and a 0.02% turnover rate, thin volume that magnified the move; the stock spiked to HK$4.395 before consolidating between HK$4.21 and HK$4.35 in the afternoon, echoing the dispersion theme across Hong Kong's leftover small caps. Fundamentals contrast with the price action: Q2 2026 revenue rose 15.79% year on year to HK$296.3 million, yet net profit was a HK$8.02 million loss, down 189% yoy, with a -2.71% net margin and EPS of -HK$0.0208, so top-line growth has not converted into earnings. The price position remains weak: down 47.59% year to date, 76.5% below the 52-week high of HK$18.51 set on 18 November 2025 and only 16.2% above the 52-week low of HK$3.74, closing under both the MA20 of HK$4.621 and MA60 of HK$4.887. PB is 0.87x on a HK$1.96 billion market cap, after a 7.13% shrink-volume pullback the prior week, though turnover under HK$340,000 limits the signal from a single session.
- Nov, 3
Rimag Group opened lower, probed 4.020 HKD in the morning session and rebounded to close at 4.160 HKD, down 3.26% from the previous close of 4.300 HKD, with an intraday range of 4.300/4.020 HKD; a recent roughly 7% and 6% two-session slide and thin trading after the interim report weighed on bids. The operating picture showed revenue growth against wider losses: Q2 2026 revenue rose 15.79% year on year to 296.3 million HKD, while net profit was -8.02 million HKD, down 189.05%, EPS was -0.0208 HKD, net margin -2.71% and operating profit -4.64 million HKD. The stock remains weak on price location, down 49.82% year to date, 77.53% below its 52-week high of 18.51 HKD and only 11.23% above its 52-week low of 3.74 HKD, while sitting below MA20 4.697 and MA60 4.901; PB is 0.830 and market value 1.874 billion HKD. However, turnover was only 563,400 HKD and turnover rate 0.040%, limiting the price signal under thin liquidity.
- Oct, 22
RIMAG Group (2522.HK) opened at its day high of HK$4.810 and closed at HK$4.610, down roughly 4.2% from the prior close, on thin turnover of HK$2.08mn and a 0.13% turnover rate, sliding to HK$4.415 at 13:39 BJ before a modest afternoon recovery. The interim report framed an initial transformation with 'the most difficult moment passing', and Q2 revenue rose 15.8% yoy to HK$296mn, yet net loss reached HK$8.0mn (-189% yoy), EPS -HK$0.0208 and ROE -1.41%, so revenue growth alongside widening losses weighed on the shares. Post-results activity stayed quiet, with weekly swings of -7.13% and +14.89%. At a 0.92x PB and HK$2.08bn market cap, the close sits well below the day's high and near the lower end of its recent range, while medical imaging penetration of about 1% offers long-term space against near-term earnings pressure.
News
Weekly Review · Weekly Recap | RIMAG GROUP +1.67%, outpacing the Hang Seng Index
Market Movers · RIMAG GROUP rose about 8%
Market Movers · Rimag Group climbs 7% in Hong Kong trading
Market Movers · RIMAG GROUP fell approximately 7%
Market Movers · Rimag Group falls 7% in Hong Kong trading
Market Movers · Rimag Group falls 6% in Hong Kong trading
